LL-37
Cathelicidin / hCAP18 fragment
- Peptide length
- 37 amino acids
Cationic antimicrobial peptide
Open the sources to check how the studies were done and what they can support.
A human host-defense peptide with antimicrobial laboratory research and small formulation-specific wound trials.
- Family
- Host-defense peptide
- Research target
- Membrane and immune signaling
- Molecular form
- Cationic antimicrobial peptide
What to know about the research
The cited venous-ulcer trial studied topical treatment in 34 participants, with outcomes differing across dose groups. It does not establish systemic antimicrobial therapy.
Check the exact compound
Distinguish the mature LL-37 peptide from hCAP18 precursor, fragments and formulated products.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries